ZULBEX 20mg gastro-resistant tablets medication leaflet

A02BC04 rabeprazole • Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors

Rabeprazole is a proton pump inhibitor used for the treatment of gastroesophageal reflux disease (GERD), gastric ulcers, and other conditions associated with excessive gastric acid secretion. It works by reducing gastric acid production, alleviating symptoms, and promoting healing of the gastric mucosa.

The medication is taken orally, as directed by a doctor, usually once daily before a meal. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as headaches, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.

Common side effects include headaches, nausea, and diarrhea. In rare cases, severe reactions such as allergic reactions or hypomagnesemia may occur. Patients should be informed of these risks before use.

General data about ZULBEX 20mg

Substance: rabeprazole

Date of last drug list: 01-01-2019

Commercial code: W56443005

Concentration: 20mg

Pharmaceutical form: gastro-resistant tablets

Quantity: 28

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA

Holder: KRKA, D.D., NOVO MESTO - SLOVENIA

Number: 8480/2016/05

Shelf life: 2 years

Pharmaceutical forms available for rabeprazole

Concentrations available for rabeprazole

10mg, 20mg